IQVIA Holdings, Inc. · NYSE:IQV

IQVIA — Quintiles — Baird 2015 Healthcare Conference

9 slides from IQVIA's conference presentation, Sep 9, 2015

  1. Slide 1: Baird 2015 Healthcare Conference

    Baird 2015 Healthcare Conference Kevin Gordon EVP Operations & CFO September 9, 2015 © Copyright 2015 Quintiles

  2. Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements refl

  3. Slide 3: Quintiles: Leader in BioPharma Services

    Quintiles Leader in BioPharma Services Strategic Agenda • Profitable growth at Growing Markets above market rates • Investments leveraging our scale Differentiated Deep & Diverse • World class customer Service Offerings Customer relationship & Relationships Relationships management • Productivity, d

  4. Slide 4: Attractive and Growing Market

    Attractive and Growing Market ~$200bn total market across both segments with increasing outsourcing penetration which drives estimated growth of 6% – 8% per year from 2014 – 2017 Approval Phase Commercial Phase I Phase II Phase III Healthcare Delivery IV Product Development Services Integrated Healt

  5. Slide 5: Track Record of Profitable Growth and Consistency

    Track Record of Profitable Growth and Consistency Long-term performance underpinned with a diversified customer portfolio Service Revenues Adjusted EBITDA(1) ’11 – ’14 CAGR = 8.1% ’11 – ’14 CAGR = 13.9% 4,400 $4,166 $4,229 800 $725 $745 $3,808 $3,692 $3,295 $606 3,300 600 $546 $490 $ Millions $ Mill

  6. Slide 6: The Quintiles Difference

    The Quintiles Difference The integration of our assets creates differentiated value Clinical Development Regulatory Submission Healthcare Delivery Preclinical Phase IV Phase I Phase II Phase III Phase IIIb Product Development Services Integrated Healthcare Services Global harmonized Deep science, th

  7. Slide 7: Quintiles: Differentiated market leader

    Quintiles Differentiated market leader Strong free cash flow Best in industry operating margins Consistent long Deep and diverse term financial customer relationships performance First mover advantage with Clinical Development Largest backlog in Informatics technology industry Market leader in Produ

  8. Slide 8: Appendix

    Appendix QUINTILES’ 8

  9. Slide 9: Adjusted EBITDA Reconciliation

    Adjusted EBITDA Reconciliation Adjusted EBITDA Reconciliation LTM period ended (In Thousands) 6/30/2015 2014 2013 2012 2011 Adjusted EBITDA: Net Income Attributable to Quintiles Transnational Holdings Inc. $352,429 $356,383 $226,591 $177,546 $241,772 Interest Expense, Net 98,424 97,179 119,571 131,3

Quintiles — Baird 2015 Healthcare Conference on 6ix